Abstract
Abbreviations:
13C-CA (carbon-13-labeled cholate), AIC (Akaike Information Criterion), BMI (body mass index), CI (confidence interval), CLD (chronic liver disease), CM (compartmental model), d4-CA (deuterium-labeled cholate), DSI (disease severity index), ER (extraction ratio), HALT-C (Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial), HCV (hepatitis C virus), HFR (hepatic filtration rate), HR (hepatic reserve), ICC (intraclass correlation coefficient), IV (intravenous), LC/MS (liquid chromatography/mass spectrometry), MM (minimal model), MSE (mean squared error), NAFLD (nonalcoholic fatty liver disease), NASH (nonalcoholic steatohepatitis), PK (pharmacokinetics), TBV (total blood volume)Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Translational ResearchReferences
- Recommendations for diagnosis, referral for liver biopsy, and treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.Mayo Clin Proc. 2015; 90: 1233-1246
- Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.Hepatology. 2018; 67: 123-133
- Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.Lancet. 2015; 386: 1546-1555
- Toward a more accurate estimate of the prevalence of hepatitis C in the United States.Hepatology. 2015; 62: 1353-1363
- Prevalence of alcoholic fatty liver disease among adults in the United States, 2001-2016.JAMA. 2019; 321: 1723-1725
- Factors associated with prevalence and treatment of primary biliary cholangitis in United States Health Systems.Clin Gastroenterol Hepatol. 2018; 16 (e6): 1333-1341
- Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review.J Hepatol. 2012; 56: 1181-1188
- Burden of gastrointestinal, liver, and pancreatic diseases in the United States.Gastroenterology. 2015; 149: 1731-1741
SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on drug use and health, 2017 and 2018.
National Center for Health Statistics. Health, United States, 2016: With chartbook on long-term trends in health. Hyattsville, MD. 2017. Available at: https://www.cdc.gov/nchs/data/hus/hus16.pdf. Accessed June 14, 2022.
- Portal-systemic shunting in patients with fibrosis or cirrhosis due to chronic hepatitis C: the minimal model for measuring cholate clearances and shunt.Aliment Pharmacol Ther. 2007; 26: 401-410
- The spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis Trial.Aliment Pharmacol Ther. 2008; 27: 798-809
- Quantitative tests of liver function measure hepatic improvement after sustained virological response: results from the HALT-C trial.Aliment Pharmacol Ther. 2009; 29: 589-601
- Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis trial.Hepatology. 2012; 55: 1019-1029
- Functional elements associated with hepatic regeneration in living donors after right hepatic lobectomy.Liver Transpl. 2013; 19: 292-304
- Noninvasive assessment of liver function.Curr Opin Gastroenterol. 2015; 31: 199-208
- Portal-systemic Shunt Fraction measured by the HepQuant-SHUNT test correlates with the hepatic venous pressure gradient (HVPG).Hepatology. 2017; 66: 348A
- Liver functional assessment by dual cholate testing is strongly correlated with direct portal pressure and Ishak fibrosis stage.Hepatology. 2017; 66: 1036A-1037A
- Deterioration of hepatic function after locoregional therapy (LRT) for hepatocellular carcinoma (HCC) measured by hepatic cholate clearance: A pilot study.J Clin Oncol. 2018; 36: 468
- Defining disease severity and measuring progression in primary sclerosing cholangitis (PSC): a comparison of the disease severity index (DSI) from the HepQuant SHUNT test with serum alkaline phosphatase (alk phos).Hepatology. 2018; 68: 1087A
- Effect of obeticholic acid on liver function in patients with fibrosis due to NASH.J Hepatol. 2019; 70: e149
- Assessing hepatic impairment in Fontan-associated liver disease using the HepQuant SHUNT test.Congenit Heart Dis. 2019; 14: 978-986
- Functional improvement measured by a reduction in HepQuant's disease severity index (DSI) after sustained viral response (SVR) in advanced hepatitis C is related to severity of hepatic impairment as determined by baseline DSI.Hepatology. 2019; 70: 334A
- Predicting clinical decompensation in patients with cirrhosis using the Hepquant-SHUNT test.Aliment Pharmacol Ther. 2021; 53: 928-938
- Defining and monitoring liver disease in chronic hepatitis C: a comparison of the disease severity index (DSI) from the HepQuant SHUNT test with Ishak fribrosis stage (IFS) from liver biopsy.Hepatology. 2018; 68: 910A
ClinicalTrials.gov. The SHUNT-V Study for Varices. Available at: https://clinicaltrials.gov/ct2/show/NCT03583996. Accessed July 20, 2022.
- The HepQuant SHUNT Test predicts the likelihood of finding esophageal varices and particularly large varices at endoscopy.Hepatology. 2021; 74: 1264A-1265A
- Sa1462: the HepQuant SHUNT Disease Severity Index (HepQuant DSI) can aid the decision to avoid endoscopic screening or surveillance for varices needing treatment [abstract].Gastroenterology. 2022; 162 (S-1178)
- The within-individual reproducibility of the disease severity index from the HepQuant SHUNT test of liver function and physiology.Transl Res. 2021; 233: 5-15
- Role of noninvasive tests in clinical gastroenterology practices to identify patients with nonalcoholic steatohepatitis at high risk of adverse outcomes: expert panel recommendations.Am J Gastroenterol. 2021; 116: 254-262
- Introduction to pharmacokinetics in clinical toxicology.(Reisfeld B, Mayeno AN, editors)Computational toxicology: volume I. Humana Press, Totowa, NJ2012: 289-312
- Noncompartmental versus compartmental modelling in clinical pharmacokinetics.Clin Pharmacokinet. 1991; 20: 253-262
- The fate of drugs in the organism. A bibliographic survey complied by the Societé Française des Sciences et Techniques Pharmaceutique.in: Working Group under the chairmanship of Hirtz, Dekker New York1974
- Compartmental modeling in the analysis of biological systems.(Reisfeld B, Mayeno AN, editors)Computational toxicology: volume I. Humana Press, Totowa, NJ2012: 391-438
- Non-compartmental Analysis.(In: Reisfeld B, Mayeno AN, editors)Computational toxicology: volume I. Humana Press, Totowa, NJ2012: 377-389
- Estimating blood volume in obese and morbidly obese patients.Obes Surg. 2006; 16: 773-776
- Physiology, blood plasma. StatPearls.StatPearls Publishing, Treasure Island (FL)2021
- Regulation of hepatic blood flow: the hepatic arterial buffer response revisited.World J Gastroenterol. 2010; 16: 6046-6057
- Chapter 2, overview. hepatic circulation: physiology and pathophysiology.Morgan & Claypool Life Sciences, San Rafael (CA)2009
- Chapter 5 - Splanchnic function and heart disease.(Nichols DG, Ungerleider RM, Spevak PJ, Greeley WJ, Cameron DE, Lappe DG, et al., editors)Critical heart disease in infants and children. 2nd ed. Mosby, Philadelphia2006: 131-141
- The volume of the liver in patients correlates to body weight and alcohol consumption.Alcohol Alcohol. 2000; 35: 531-532
- Estimation of standard liver volume for liver transplantation in the Korean population.Liver Transpl. 2004; 10: 779-783
- Standard liver volume in the Caucasian population.Liver Transpl. 1999; 5: 366-368
- Hepatic vasculature: a conceptual review.Gastroenterology. 1977; 73: 1163-1169
- Hepatic blood flow: morphologic aspects and physiologic regulation.Int Rev Physiol. 1980; 21: 1-63
- Splanchnic circulation.BJA Educ. 2016; 16: 66-71
- Determination of the hepatic arterial blood flow and oxygen supply in man by clamping the hepatic artery during surgery.J Clin Investig. 1962; 41: 447-454
- Relationship between hepatic blood flow and overall metabolism: the hepatic arterial buffer response.Fed Proc. 1983; 42: 1662-1666
- Adenosine as putative regulator of hepatic arterial flow (the buffer response).Am J Physiol Heart Circ Physiol. 1985; 248: H331-H3H8
- Clinical pharmacokinetics.Annu Rev Pharmacol Toxicol. 1979; 19: 105-127
Rowland M, Tozer TN. Clinical pharmacokinetics: concepts and applications: Williams & Wilkins; 1995.
- The Continuing Importance of Bile Acids in Liver and Intestinal Disease.Arch Intern Med. 1999; 159: 2647-2658
- Plasma clearance of oral and intravenous cholic acid in subjects with and without chronic liver disease.Gut. 1980; 21: 123
- The influence of conjugation of cholic acid on its uptake and secretion: hepatic extraction of taurocholate and cholate in the dog.J Physiol. 1967; 189: 337-350
- Considering age variation when coining drugs as high versus low hepatic extraction ratio.Drug Metab Dispos. 2016; 44: 1099
- Chapter 2, pharmacokinetic study design and data interpretation. handbook of essential pharmacokinetics, pharmacodynamics and drug metabolism for industrial scientists.Springer US, Boston, MA2002: 3-28
- A physiological approach to hepatic drug clearance.Clin Pharmacol Ther. 1975; 18: 377-390
- Perfusion-limited effects of plasma drug binding on hepatic drug extraction.Life Sci. 1976; 19: 125-130
- Kinetic analysis of albumin-mediated uptake of warfarin by perfused rat liver.J Pharmacokinet Biopharm. 1988; 16: 165-181
- The phenomenon of albumin-mediated hepatic uptake of organic anion transport polypeptide substrates: prediction of the in vivo uptake clearance from the in vitro uptake by isolated hepatocytes using a facilitated-dissociation model.Drug Metab Dispos. 2018; 46: 259
- Chapter 4, absorption. handbook of essential pharmacokinetics, pharmacodynamics and drug metabolism for industrial scientists.Springer US, Boston, MA2002: 35-72
- Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies.J Pharmacokinet Pharmacodyn. 2007; 34: 711-726
- Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption.Antimicrob Agents Chemother. 2008; 52: 2138-2148
- A disease severity index based on dual cholate clearances and shunt outperforms biopsy at predicting clinical outcomes in chronic Hepatitis C.Gastroenterology. 2013; 144 (S-951-S-2)
- Significant alteration of the portal ciculation in over half of the chronic HCV patients with Ishak fibrosis stage F0-F2.Hepatology. 2011; 54: 1328A-1329A
- A guideline of selecting and reporting intraclass correlation coefficients for reliability research.J Chiropr Med. 2016; 15: 155-163
- Forming inferences about some intraclass correlation coefficients.Psychol Methods. 1996; 1: 30-46
- Incorrect least-squares regression coefficients in method-comparison analysis.Clin Chem. 1979; 25: 432-438
- Measuring agreement in method comparison studies.Stat Methods Med Res. 1999; 8: 135-160